407 related articles for article (PubMed ID: 15022320)
1. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor.
Lin SK; Kok SH; Yeh FT; Kuo MY; Lin CC; Wang CC; Goldring SR; Hong CY
Arthritis Rheum; 2004 Mar; 50(3):785-93. PubMed ID: 15022320
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M-induced CCL2 transcription in osteoblastic cells is mediated by multiple levels of STAT-1 and STAT-3 signaling: an implication for the pathogenesis of arthritis.
Kok SH; Hong CY; Kuo MY; Wang CC; Hou KL; Lin YT; Galson DL; Lin SK
Arthritis Rheum; 2009 May; 60(5):1451-62. PubMed ID: 19404962
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.
Chipoy C; Berreur M; Couillaud S; Pradal G; Vallette F; Colombeix C; Rédini F; Heymann D; Blanchard F
J Bone Miner Res; 2004 Nov; 19(11):1850-61. PubMed ID: 15476586
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis.
Lin SK; Chang HH; Chen YJ; Wang CC; Galson DL; Hong CY; Kok SH
Arthritis Rheum; 2008 Oct; 58(10):3145-56. PubMed ID: 18821707
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells.
Nagata T; Kai H; Shibata R; Koga M; Yoshimura A; Imaizumi T
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):588-93. PubMed ID: 12615664
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
Chun KS; Kim SH; Song YS; Surh YJ
Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts.
Tong L; Smyth D; Kerr C; Catterall J; Richards CD
Cell Signal; 2004 Oct; 16(10):1123-32. PubMed ID: 15240007
[TBL] [Abstract][Full Text] [Related]
11. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.
Hintzen C; Quaiser S; Pap T; Heinrich PC; Hermanns HM
Arthritis Rheum; 2009 Jul; 60(7):1932-43. PubMed ID: 19565514
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway.
Lo RK; Wong YH
Cell Signal; 2006 Dec; 18(12):2143-53. PubMed ID: 16781847
[TBL] [Abstract][Full Text] [Related]
13. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
[TBL] [Abstract][Full Text] [Related]
14. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
15. Oxidized LDL induces transcription factor activator protein-1 in rat mesangial cells.
Wu ZL; Wang YC; Zhou Q; Ge YQ; Lan Y
Cell Biochem Funct; 2003 Sep; 21(3):249-56. PubMed ID: 12910478
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway.
Li WQ; Dehnade F; Zafarullah M
J Immunol; 2001 Mar; 166(5):3491-8. PubMed ID: 11207308
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor induces hypertrophic responses and Stat5 activation in rat ventricular cardiomyocytes.
Rebsamen MC; Arrighi JF; Juge-Aubry CE; Vallotton MB; Lang U
J Mol Cell Cardiol; 2000 Apr; 32(4):599-610. PubMed ID: 10756117
[TBL] [Abstract][Full Text] [Related]
18. Involvement of tyrosine phosphatase PTP1D in the inhibition of interleukin-6-induced Stat3 signaling by alpha-thrombin.
Gunaje JJ; Bhat GJ
Biochem Biophys Res Commun; 2001 Oct; 288(1):252-7. PubMed ID: 11594781
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways.
Ho AW; Wong CK; Lam CW
Immunobiology; 2008; 213(7):533-44. PubMed ID: 18656701
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ.
Demyanets S; Kaun C; Rychli K; Pfaffenberger S; Kastl SP; Hohensinner PJ; Rega G; Katsaros KM; Afonyushkin T; Bochkov VN; Paireder M; Huk I; Maurer G; Huber K; Wojta J
Basic Res Cardiol; 2011 Mar; 106(2):217-31. PubMed ID: 21174212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
